Hepatic effects of flunixin-meglumin in LPS-induced sepsis

Fundamental and Clinical Pharmacology

Volumn 24, Issue 6, 2010, Pages 759-769

  Ávila, Thiago Vinicius ^a   Bastos Pereira, Amanda Leite ^a   De Oliveira Christoff, Adriana ^a   Da Silva Soley, Bruna ^a   Queiroz Telles, José Ederaldo ^a   Eler, Gabrielle Jacklin ^b   Bracht, Adelar ^b   Roberto Zampronio, Aleksander ^a   Acco, Alexandra ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Flunixin meglumin; Liver; LPS; Oxidative stress; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; FLUNIXIN MEGLUMINE; LIPID PEROXIDASE; LIPOPOLYSACCHARIDE; LIVER ENZYME; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GLUCONEOGENESIS; HEPATITIS; HISTOPATHOLOGY; LIVER FUNCTION; LIVER INJURY; LIVER STRUCTURE; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SEPSIS; UREA CYCLE;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CATALASE; CLONIXIN; GLUCONEOGENESIS; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; MALE; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; SEPSIS; SUPEROXIDE DISMUTASE; UREA;

EID: 78349261256     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00804.x     Document Type: Article

References (54)

1. Bone R.C., Grodzin C.J., Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest (1997) 112 235-243.
2. Brix-Christensen V., Andersen S.K., Andersen R. et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology (2004) 100 861-870.
3. Marik P.E., Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. (2004) 30 748-756.
4. Marik P.E., Zaloga G.P. Therapeutic sedation: has its time come? Crit. Care Med. (2002) 30 949-952.
5. Fry D.E., Pearlstein L., Fulton R.L., Polk H.C. Jr Multiple system organ failure. The role of uncontrolled infection. Arch. Surg. (1980) 115 136-140.
6. Beal A.L., Cerra F.B. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA (1994) 271 226-233.
7. Ardawi M.S., Ashy A.A., Jamal Y.S., Khoja S.M. Metabolic control of hepatic gluconeogenesis in response to sepsis. J. Lab. Clin. Med. (1989) 114 579-586.
8. Chang C.K., Moskal S.F. 2nd, Srivenugopal K.S., Schumer W. Altered levels of mRNA encoding enzymes of hepatic glucose metabolism in septic rats. Circ. Shock (1993) 41 35-39.
9. Crouser E.D., Dorinsky P.M. Metabolic consequences of sepsis. Correlation with altered intracellular calcium homeostasis. Clin. Chest Med. (1996) 17 249-261.
10. Eipel C., Bordel R., Nickels R.M., Menger M.D., Vollmar B. Impact of leukocytes and platelets in mediating hepatocyte apoptosis in a rat model of systemic endotoxemia. Am. J. Physiol. Gastrointest. Liver Physiol. (2004) 286 G769-G776.
11. Salkowski C.A., Detore G., Franks A., Falk M.C., Vogel S.N. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. (1998) 66 3569-3578.
12. Sugino K., Dohi K., Yamada K., Kawasaki T. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery (1989) 105 200-206.
13. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. (1990) 87 1620-1624.
14. Deitch E.A. Multiple organ failure. Pathophysiology and potential future therapy. Ann. Surg. (1992) 216 117-134.
15. Salvemini D., Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic. Biol. Med. (2002) 33 1173-1185.
16. Bhattacharyya S., Brown D.E., Brewer J.A., Vogt S.K., Muglia L.J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood (2007) 109 4313-4319.
17. Chen H.W., Kuo H.T., Chai C.Y., Ou J.L., Yang R.C. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J. Endotoxin Res. (2007) 13 15-23.
18. Yazar E., Er A., Uney K., Altunok V., Elmas M. Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice. J. Vet. Med. A Physiol. Pathol. Clin. Med. (2007) 54 352-355.
19. Cheng P.Y., Lee Y.M., Wu Y.S., Chang T.W., Jin J.S., Yen M.H. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem. Pharmacol. (2007) 73 793-804.
20. Alexander J.J., Jacob A., Cunningham P., Hensley L., Quigg R.J. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem. Int. (2008) 52 447-456.
21. Hevia H., Varela-Rey M., Corrales F.J. et al. 5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology (2004) 39 1088-1098.
22. Lee S.J., Lim K.T. Inhibitory effect of 30-kDa phytoglycoprotein on expression of TNF-alpha and COX-2 via activation of PKCalpha and ERK 1/2 in LPS-stimulated RAW 264.7 cells. Mol. Cell. Biochem. (2008) 317 151-159.
23. Balk R.A. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis. Mon. (2004) 50 168-213.
24. Toutain P.L., Autefage A., Legrand C., Alvinerie M. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. J. Vet. Pharmacol. Ther. (1994) 17 459-469.
25. Luthman J., Kindahl H., Jacobsson S.O. The influence of flunixin on the response to Salmonella typhimurium endotoxin in calves. Acta Vet. Scand. (1989) 30 295-300.
26. Daels P.F., Stabenfeldt G.H., Hughes J.P., Odensvik K., Kindahl H. Effects of flunixin meglumine on endotoxin-induced prostaglandin F2 alpha secretion during early pregnancy in mares. Am. J. Vet. Res. (1991) 52 276-281.
27. Little D., Brown S.A., Campbell N.B., Moeser A.J., Davis J.L., Blikslager A.T. Effects of the cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunum. Am. J. Vet. Res. (2007) 68 614-624.
28. Mouithys-Mickalad A.M., Zheng S.X., Deby-Dupont G.P. et al. In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic. Res. (2000) 33 607-621.
29. Drury R.A.B., Wallington E.A.. Preparation and fixation of tissues. Carletons histological tecnique, 5th edn, Oxford Univ. Press, Oxford, 1980.
30. Culling C.F.A., Allison R.T., Barr W.T. Cellular pathology technique. Butterworth and Co., London, 1985.
31. Beautler E., Litchman M.A., Coller B.S., Kipps T.J. Hematology. McGraw Hill, New York, 1995.
32. Cheng Z., Moore J., Yu L. High-throughput relative DPPH radical scavenging capacity assay. J. Agric. Food. Chem. (2006) 54 7429-7436.
33. Gao R.M., Yuan Z.B., Zhao Z.Q., Gao X.R. Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activity. Bioelectrochem. Bioenerg. (1998) 45 41-45.
34. Aebi H. Catalase in vitro. Methods Enzymol. (1984) 105 121-126.
35. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids (1991) 26 853-856.
36. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. (1968) 25 192-205.
37. Scholz R., Hansen W., Thurman R.G. Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver. Eur. J. Biochem. (1973) 38 64-72.
38. Bergmeyer H.U.. Methods of enzymatic analysis. Academic Press, London, 1974, pp. 1794-1801.
39. Bracht A., Ishii-Iwamoto E.L. Métodos de laboratório em Bioquímica. Manole, São Paulo, 2003, pp. 275-289.
40. Hsu D.Z., Li Y.H., Chien S.P., Liu M.Y. Effects of sesame oil on oxidative stress and hepatic injury after cecal ligation and puncture in rats. Shock (2004) 21 466-469.
41. Neyrinck A.M., Mouson A., Delzenne N.M. Dietary supplementation with laminarin, a fermentable marine beta (1-3) glucan, protects against hepatotoxicity induced by LPS in rat by modulating immune response in the hepatic tissue. Int. Immunopharmacol. (2007) 7 1497-1506.
42. Gutteridge J.M., Mitchell J. Redox imbalance in the critically ill. Br. Med. Bull. (1999) 55 49-75.
43. Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. (1995) 41 1819-1828.
44. Sakaguchi S., Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol. Med. Microbiol. (2006) 47 167-177.
45. Victor V.M., Rocha M., De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int. Immunopharmacol. (2004) 4 327-347.
46. Kantrow S.P., Taylor D.E., Carraway M.S., Piantadosi C.A. Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch. Biochem. Biophys. (1997) 345 278-288.
47. Munker R., Greither L., Darsow M., Ellwart J.W., Mailhammer R., Wilmanns W. Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changes. Acta Haematol. (1993) 90 77-83.
48. Portoles M.T., Catala M., Anton A., Pagani R. Hepatic response to the oxidative stress induced by E. coli endotoxin: glutathione as an index of the acute phase during the endotoxic shock. Mol. Cell. Biochem. (1996) 159 115-121.
49. Galati G., Tafazoli S., Sabzevari O., Chan T.S., O'Brien P.J. Idiosyncratic NSAID drug induced oxidative stress. Chem. Biol. Interact. (2002) 142 25-41.
50. Konyalioglu S., Er A., Uney K., Elmas M., Yazar E. Effect of flunixin meglumin on the antioxidant status in endotoxemia. Acta Vet. (beograd.), (2007) 57 241-246.
51. Carbonell L.F., Nadal J.A., Llanos M.C., Hernandez I., Nava E., Diaz J. Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit. Care Med. (2000) 28 2002-2006.
52. Zhang G.G., Bai Y.P., Chen M.F. et al. Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul. Pharmacol (2008) 48 115-121.
53. Nelson D.L., Cox M.M. Lehninger principles of biochemistry, 4th edn, Worth, New York, 2005, 1200 p.
54. Oppert M., Engel C., Brunkhorst F.M. et al. Acute renal failure in patients with severe sepsis and septic shock - a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol. Dial. Transplant. (2008) 23 904-909.